New Insights from the SILVER Study; A 50 % Reduction in Calcineurin Inhibitors at Day 30 Achieves a Temporary Renal-Sparing Effect but Does not Impact on Long-Term Renal Function after Liver Transplantation

Authors :: Bettina M. Buchholz
Darius F. Mirza
Andreas A. Schnitzbauer
James Ferguson
Peter Nightingale
Edward K. Geissler
Source :: Transplantation. 102:S122
Publication Year :: 2018
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2018.

Subjects :: Calcineurin
Transplantation
medicine.medical_specialty
business.industry
medicine.medical_treatment
medicine
Urology
Renal function
Liver transplantation
business
Reduction (orthopedic surgery)
Term (time)

Full Text Access

Tools